IP Verse

Mrna Therapy For Argininosuccinate Synthetase Deficiency

Patent No. EP3501605 (titled "Mrna Therapy For Argininosuccinate Synthetase Deficiency") was filed by Translate BIO on Oct 22, 2014. The application was issued on Jun 28, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AWA SWEDENMar 28, 2024AWA SWEDEN
AWA SWEDENMar 28, 2024EIP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3501605

TRANSLATE BIO
Application Number
EP18205194A
Filing Date
Oct 22, 2014
Status
Revoked
Jul 11, 2025
Publication Date
Jun 28, 2023
External Links
Slate, Register , Google Patents